NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
April 5, 2022
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
